Drug discovery & development - A to Z
This page contains links to content about drug discovery and development - the process by which scientists find and develop new treatments for people with cancer.
Cancer Research UK has a long history in developing new cancer drugs.
Related categories
Drug discovery & development is a sub-category of Research and trials and Clinical and translational research
Browse content about Drug discovery & development
- Developing new cancer drugs
- Dr Chris Jones
- Dr David Tuveson
- Our progress and achievements in the 1970s
- Our progress and achievements in the 1990s
- Our research into drug discovery and development
- Prof Caroline Dive
- Prof Duncan Jodrell
- Prof Gavin Halbert
- Prof Herbie Newell
- Prof Nicol Keith
- Prof Richard Begent
- Prof Steve Jackson
- Professor Michael Shipman
- Research into cancer biology
- The story of temozolomide - transcript
- Discovering new cancer drugs
- Dr Darren Hargrave
- Our progress and achievements from 1902 to 1959
- Our progress and achievements in the 1980s
- Our progress in developing cancer drugs
- Prof Bass Hassan
- Prof Chris Paraskeva
- Prof Gareth Williams
- Prof Gordon Jayson
- Prof Jeff Evans
- Prof Paul Workman
- Prof Stan Kaye
- Professor David Thurston
- Professor Shankar Balasubramanian
- The story of temozolomide
- Press Release: 'Treatment alliance' needed to save more children's lives from cancer
6 October 2012 - Press Release: Scientists find new drug target for hard-to-treat leukaemia
29 March 2012 - Press Release: Cancer Research Technology appoints new chairman to its board of directors
13 October 2011 - Press Release: Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing
23 March 2011 - Press Release: Powerful online cancer drug discovery database unveiled
29 November 2010 - Press Release: Cancer Research UK and AstraZeneca sign deal to trial first-of-kind cancer drug
13 September 2010 - Press Release: CRT and ValiRx sign licensing deal to develop prostate cancer treatment
12 August 2010 - Press Release: Treatment reduces dangerous side effects of cancer treatment in children
20 July 2010 - News story: Sea sponge drug may extend advanced breast cancer survival
11 June 2010 - Press Release: CRT announces partnership with Cephalon to co-develop a new class of anti-cancer drugs
22 March 2010
- Press Release: Diabetes treatment doubles skin cancer drug's effectiveness
31 March 2012 - News story: Ras protein discovery could lead to drug
4 December 2011 - News story: Gene may provide new target for breast cancer drug development
15 July 2011 - News story: Experimental melanoma drug shows promise in phase-III trial
20 January 2011 - Press Release: Cancer Research UK and immatics biotechnologies launch trial for brain cancer
19 October 2010 - Press Release: CRT and Bayer Schering Pharma to investigate new therapeutic approach in gynaecological and oncological diseases
25 August 2010 - Press Release: Cancer Research UK launches medicine manufacturing hub for life-saving research
30 July 2010 - Press Release: 'Skills Swap' to exploit expertise for patient benefit
13 July 2010 - Press Release: UK-NZ collaboration to home in on new anti-cancer drug for leukaemia
22 April 2010 - Press Release: Exploiting cancer's 'double agent' could lead to new treatments for bowel cancer
15 March 2010







Read article